Colin Goding: "Phenotype-switching in cancer"
14.00 Uhr
Colin R Goding, Ludwig Institute for Cancer Research, University of Oxford, UK
"Phenotype-switching in cancer"
Seminar series TRR 305 - Striking a moving target: From mechanisms of metastatic organ colonisation to novel systemic therapies
Hybrid (Präsenz in Regensburg in H5, Seminarraum (Raum 2.13), Universitätsklinikum Regensburg)
Zoom-link, Nicht-Mitglieder des TRR 305 kontaktieren bitte: martina.ellerbeck@ukr.de
Zurück zum Newsroom